LeadIQ logo
Learn more at LeadIQ.com
OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH Employee Directory

Biotechnology ResearchBerlin, Germany2-10 Employees

OMEICOS Therapeutics has discovered a series of metabolically robust synthetic analogues of omega-3 fatty acid-derived epoxyeicosanoids that have the potential to treat mitochondrial dysfunction, inflammatory, cardiovascular and other diseases. Epoxyeicosanoids activate cell type-specific endogenous pathways that promote organ and tissue protection. 
OMEICOS’ small molecules are orally available and show improved biological activity and pharmacokinetic properties compared to their natural counterparts. The currently active PMD-OPTION Phase 2a clinical study is evaluating OMEICOS’ lead development program OMT-28 in patients with Primary Mitochondrial Disease.

Find OMEICOS Therapeutics GmbH employees' phone numbers or email addresses

OMEICOS Therapeutics GmbH Global Highlights

Location
Employees

Europe
14

Minus sign iconPlus sign icon
  • Germany
    13
  • Switzerland
    1

OMEICOS Therapeutics GmbH's Leadership

Contact profiles from OMEICOS Therapeutics GmbH

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is OMEICOS Therapeutics GmbH known for?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH was founded in 2013 operates in the Biotechnology Research industry. The company's main headquarters is located in Robert-Roessle-Strasse 10 Berlin, 13125 DE; you can contact the main corporate office by phone at . Explore OMEICOS Therapeutics GmbH's company overview page for more information.

What is OMEICOS Therapeutics GmbH's most common email format?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more OMEICOS Therapeutics GmbH email formats with LeadIQ.

How many employees does OMEICOS Therapeutics GmbH have currently?

Minus sign iconPlus sign icon
OMEICOS Therapeutics GmbH has approximately 9 employees as of May 2024. These team members are located across 1 continents, including Europe.

Who are OMEICOS Therapeutics GmbH's key employees and leadership?

Minus sign iconPlus sign icon

As of May 2024, OMEICOS Therapeutics GmbH's key employees include:

  • Chief Executive Officer: R. F.
  • Chief Business Officer: S. R.
  • Vice President Operations & Ip: K. U.
  • Head In-Vivo Pharmacology: J. L.
  • Drug Safety Officer: H. J. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.